Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 20/20 | 0.78 |
| ▸ | ITGA5 | P08648 | 20/20 | 0.78 |
| ▸ | ITGB3 | P05106 | 16/20 | 0.78 |
| ▸ | ITGAV | P06756 | 16/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4065796 | 0.87 | ITGB1 (1.00) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4244128 | 0.77 | ITGB1 (0.65) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4927458 | 0.76 | ITGB3 (1.00) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4070827 | 0.76 | ITGB3 (1.00) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4068178 | 0.75 | ITGB3 (0.84) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4067631 | 0.75 | ITGB3 (1.00) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4070162 | 0.75 | ITGB3 (0.88) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4072158 | 0.74 | ITGB3 (0.82) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4068834 | 0.74 | ITGB3 (0.88) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4070455 | 0.73 | ITGB3 (0.81) | ITGB1ITGA5ITGB3ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049490-A1 | N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS | Astra Zeneca AB (SE) | 2009-04-22 | — | — | EP | disclosed |
| WO-2007141473-A1 | N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS | ASTRAZENECA AB (SE) | 2007-12-13 | — | — | WO | disclosed |